Claudin‐4 immunohistochemistry is highly effective in distinguishing adenocarcinoma from malignant mesothelioma in effusion cytology

Publisher： John Wiley & Sons Inc

E-ISSN： 1934-6638|122|4|299-306

ISSN： 1934-662x

Source： CANCER CYTOPATHOLOGY, Vol.122, Iss.4, 2014-04, pp. : 299-306

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The diagnosis of malignant mesothelioma in effusion cytology

By  

CANCER CYTOPATHOLOGY, Vol. 121, Iss. 12, 2013-12 ,pp. : 703-707

John Wiley & Sons Inc

Access to resources Recommend Favorite

The evolving role of effusion cytology in the diagnosis of malignant mesothelioma

By  

CYTOPATHOLOGY, Vol. 26, Iss. 3, 2015-06 ,pp. : 137-138

John Wiley & Sons Inc

Access to resources Recommend Favorite

A combination of MTAP and BAP1 immunohistochemistry in pleural effusion cytology for the diagnosis of mesothelioma

By  

CANCER CYTOPATHOLOGY, Vol. 126, Iss. 1, 2018-01 ,pp. : 54-63

John Wiley & Sons Inc

Access to resources Recommend Favorite

Small orangiophilic squamous‐like cells: An underrecognized and useful morphological feature for the diagnosis of malignant mesothelioma in pleural effusion cytology

By  

CANCER CYTOPATHOLOGY, Vol. 122, Iss. 1, 2014-01 ,pp. : 70-75

John Wiley & Sons Inc

Access to resources Recommend Favorite

Malignant pleural effusion from papillary thyroid carcinoma diagnosed by pleural effusion cytology: A case report

By  

DIAGNOSTIC CYTOPATHOLOGY, Vol. 46, Iss. 2, 2018-02 ,pp. : 204-207

John Wiley & Sons Inc

Access to resources Recommend Favorite